In these cases, independently of the immunophenotype exhibited by tumor cells, MYC, BCL2, and BCL6 rearrangements should be investigated for the differential diagnosis among HGBL DH/TH, HGBL NOS, and Burkitt lymphoma (Fig. 3). The gene discussed is BCL6; the disease is Burkitt lymphoma.